The Win-Win Wth Virtual Visits – Better Experiences, Better Data

The clinical research industry is shifting towards decentralized trials and virtual visits due to factors such as the COVID-19 pandemic, the need for diversity, and a more representative patient population. Virtual visits are becoming increasingly popular as they reduce the travel burden for patients, simplify trial participation, and enable more patient-centric research. This approach allows researchers to engage with patients remotely, making it feasible for patients with rare conditions or those who are immunocompromised to participate. Remote tools like eConsent and eCOA further enhance the patient experience and streamline the research process.

The integration of virtual visits into clinical trials offers a mutually beneficial scenario for both patients and researchers. For patients, virtual visits offer convenience and comfort, improving their participation and engagement in clinical trials. For researchers, virtual visits and digital platforms provide efficient data collection and management, leading to more accurate and reliable results.

By adopting remote tactics like eConsent and eCOA, discover how researchers can design studies with the needs of the participant in mind and, by doing so, speed enrollment, keep engagement high, and produce more complete and accurate safety and efficacy data.